broad-spectrum antivirals

  • NAVIPP project poised to contribute to WHO’s new R&D Blueprint for Epidemics

    WHO’s New Pathogens Prioritization Framework In 2015, the World Health Organization (WHO), at the request of almost 200 member states, developed its first Research & Development (R&D) Blueprint for Action to Prevent Epidemics focusing on a number of specific severe infectious diseases for which no medical countermeasures (MCMs) were available. Launched for the first time…

    (…)